STOCK TITAN

[Form 4] EASTMAN CHEMICAL CO Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Eastman Chemical (EMN) director transaction: On 10/07/2025, a director acquired 487 phantom stock units under the Directors' Deferred Compensation Plan, recorded at $0 as an automatic deferral of a portion of annual retainer fees. Following this, the director beneficially owned 1,267 phantom stock units. These units track the value of common stock and are payable only in cash after the director’s service ends. The total includes 19 units credited since April 7, 2025 from dividend-equivalent reinvestments.

Transazione del direttore di Eastman Chemical (EMN): Il 10/07/2025, un direttore ha acquisito 487 unità di azioni fantasma nell'ambito del Directors' Deferred Compensation Plan, registrate a $0 come differimento automatico di una parte dei compensi annui del mandato. Successivamente, il direttore deteneva legalmente 1.267 unità di azioni fantasma. Queste unità seguono il valore delle azioni comuni e sono pagabili solo in contanti una volta terminato il servizio del direttore. Il totale include 19 unità accreditate dal 7 aprile 2025 provenienti da reinvestimenti di importi equivalenti ai dividendi.

Transacción de director de Eastman Chemical (EMN): El 10/07/2025, un director adquirió 487 unidades de acciones fantasma bajo el Directors' Deferred Compensation Plan, registradas en $0 como diferimiento automático de una parte de las tarifas anuales de retención. Posteriormente, el director pasó a poseer beneficiosamente 1.267 unidades de acciones fantasma. Estas unidades siguen el valor de las acciones comunes y solo se pagan en efectivo después de que termine el servicio del director. El total incluye 19 unidades acreditadas desde el 7 de abril de 2025 por reinversiones de importes equivalentes a dividendos.

Eastman Chemical (EMN) 이사 거래: 2025년 10월 7일에 한 이사는 Directors' Deferred Compensation Plan에 따라 487개의 팬텀 주식 단위를 취득했으며, 연간 임금의 자동 연기 부분으로 $0에 기록되었습니다. 그 후 해당 이사는 실질적으로 1,267개의 팬텀 주식 단위를 보유하게 되었습니다. 이 단위는 보통주의 가치를 추적하며 이사 임기 종료 후에만 현금으로 지급됩니다. 총액에는 2025년 4월 7일 이후 배당금 등가분 reinvestment로 19단위가 포함되어 있습니다.

Transaction d’un administrateur chez Eastman Chemical (EMN) : Le 07/10/2025, un administrateur a acquis 487 unités d’actions fantômes dans le cadre du Directors' Deferred Compensation Plan, enregistrées à 0 $ en tant que report automatique d’une partie des honoraires annuels de direction. Suite à cela, l’administrateur détenait bénéficiairement 1 267 unités d’actions fantômes. Ces unités suivent la valeur des actions ordinaires et ne sont versées qu’en espèces après la fin du mandat de l’administrateur. Le total inclut 19 unités créditées depuis le 7 avril 2025 provenant des réinvestissements des montants équivalents aux dividendes.

Transaktion eines Eastman Chemical-Direktors (EMN): Am 07.10.2025 erwarb ein Direktor im Rahmen des Directors' Deferred Compensation Plan 487 Phantomaktieneinheiten, die mit 0 $ als automatisches Abzugsverfahren eines Teils der jährlichen Direktorenhonorare verbucht wurden. Anschließend war der Direktor rechzeitig rechtlich Eigentümer von 1.267 Phantomaktieneinheiten. Diese Einheiten verfolgen den Wert der Stammaktien und sind erst nach Beendigung der Dienstzeit des Direktors bar zahlbar. Die Gesamtsumme enthält 19 Einheiten, die seit dem 07.04.2025 aus Dividendenäquivalent-Reinvestitionen gutgeschrieben wurden.

صفقة مدير لدى Eastman Chemical (EMN): في 07/10/2025، اشترى مدير 487 وحدة أسهم فانتوم ضمن خطة التعويض المؤجل للمديرين، ومسجّلة بقيمة 0 دولار كتأجيل تلقائي لجزء من رسوم الخدمة السنوية. بعد ذلك أصبح المدير يمتلك فعلياً 1,267 وحدة فانتوم. تتعقب هذه الوحدات قيمة الأسهم العادية ويتم دفعها نقداً فقط بعد انتهاء خدمة المدير. الإجمالي يشمل 19 وحدة مُسجّلة منذ 07/04/2025 نتيجة إعادة استثمار مبالغ مكافئة الأرباح.

Eastman Chemical (EMN) 董事交易: 2025年10月7日,一名董事在董事会延迟薪酬计划(Directors' Deferred Compensation Plan)下取得了487单位幻影股票,记为0美元,作为部分年度董事费的自动递延。随后,该董事实际持有1,267单位幻影股票。这些单位跟踪普通股的价值,且在董事任期结束后才以现金支付。合计中还包括自2025年4月7日起因股息等值 reinvestment 而新增的19单位。

Positive
  • None.
Negative
  • None.

Transazione del direttore di Eastman Chemical (EMN): Il 10/07/2025, un direttore ha acquisito 487 unità di azioni fantasma nell'ambito del Directors' Deferred Compensation Plan, registrate a $0 come differimento automatico di una parte dei compensi annui del mandato. Successivamente, il direttore deteneva legalmente 1.267 unità di azioni fantasma. Queste unità seguono il valore delle azioni comuni e sono pagabili solo in contanti una volta terminato il servizio del direttore. Il totale include 19 unità accreditate dal 7 aprile 2025 provenienti da reinvestimenti di importi equivalenti ai dividendi.

Transacción de director de Eastman Chemical (EMN): El 10/07/2025, un director adquirió 487 unidades de acciones fantasma bajo el Directors' Deferred Compensation Plan, registradas en $0 como diferimiento automático de una parte de las tarifas anuales de retención. Posteriormente, el director pasó a poseer beneficiosamente 1.267 unidades de acciones fantasma. Estas unidades siguen el valor de las acciones comunes y solo se pagan en efectivo después de que termine el servicio del director. El total incluye 19 unidades acreditadas desde el 7 de abril de 2025 por reinversiones de importes equivalentes a dividendos.

Eastman Chemical (EMN) 이사 거래: 2025년 10월 7일에 한 이사는 Directors' Deferred Compensation Plan에 따라 487개의 팬텀 주식 단위를 취득했으며, 연간 임금의 자동 연기 부분으로 $0에 기록되었습니다. 그 후 해당 이사는 실질적으로 1,267개의 팬텀 주식 단위를 보유하게 되었습니다. 이 단위는 보통주의 가치를 추적하며 이사 임기 종료 후에만 현금으로 지급됩니다. 총액에는 2025년 4월 7일 이후 배당금 등가분 reinvestment로 19단위가 포함되어 있습니다.

Transaction d’un administrateur chez Eastman Chemical (EMN) : Le 07/10/2025, un administrateur a acquis 487 unités d’actions fantômes dans le cadre du Directors' Deferred Compensation Plan, enregistrées à 0 $ en tant que report automatique d’une partie des honoraires annuels de direction. Suite à cela, l’administrateur détenait bénéficiairement 1 267 unités d’actions fantômes. Ces unités suivent la valeur des actions ordinaires et ne sont versées qu’en espèces après la fin du mandat de l’administrateur. Le total inclut 19 unités créditées depuis le 7 avril 2025 provenant des réinvestissements des montants équivalents aux dividendes.

Transaktion eines Eastman Chemical-Direktors (EMN): Am 07.10.2025 erwarb ein Direktor im Rahmen des Directors' Deferred Compensation Plan 487 Phantomaktieneinheiten, die mit 0 $ als automatisches Abzugsverfahren eines Teils der jährlichen Direktorenhonorare verbucht wurden. Anschließend war der Direktor rechzeitig rechtlich Eigentümer von 1.267 Phantomaktieneinheiten. Diese Einheiten verfolgen den Wert der Stammaktien und sind erst nach Beendigung der Dienstzeit des Direktors bar zahlbar. Die Gesamtsumme enthält 19 Einheiten, die seit dem 07.04.2025 aus Dividendenäquivalent-Reinvestitionen gutgeschrieben wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SLAGER DONALD W

(Last) (First) (Middle)
200 SOUTH WILCOX DRIVE

(Street)
KINGSPORT TN 37660

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units $0(1) 10/07/2025 A 487(2) (1) (1) Common Stock 487(2) $0(2) 1,267(3) D
Explanation of Responses:
1. Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director.
2. Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash.
3. Includes 19 unit credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Donald W. Slager 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Eastman Chem Co

NYSE:EMN

EMN Rankings

EMN Latest News

EMN Latest SEC Filings

EMN Stock Data

6.68B
113.81M
0.78%
91.74%
2.59%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
KINGSPORT